Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001437749-26-013362
Filing Date
2026-04-27
Accepted
2026-04-27 06:21:13
Documents
8
Period of Report
2026-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K athe20260427_6k.htm 6-K 10818
2 EXHIBIT 99.1 ex_951141.htm EX-99.1 5295
3 page01.jpg GRAPHIC 253504
4 page02.jpg GRAPHIC 125799
5 page03.jpg GRAPHIC 108017
6 page04.jpg GRAPHIC 202558
7 page05.jpg GRAPHIC 224627
8 page06.jpg GRAPHIC 102337
  Complete submission text file 0001437749-26-013362.txt   1418106
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE Australia 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 26896417
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)